Phathom Pharmaceuticals (PHAT) Current Leases (2022 - 2025)
Historic Current Leases for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $591000.0.
- Phathom Pharmaceuticals' Current Leases fell 1308.82% to $591000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $591000.0, marking a year-over-year decrease of 1308.82%. This contributed to the annual value of $501000.0 for FY2024, which is 3099.17% down from last year.
- Per Phathom Pharmaceuticals' latest filing, its Current Leases stood at $591000.0 for Q3 2025, which was down 1308.82% from $238000.0 recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Current Leases ranged from a high of $730000.0 in Q1 2024 and a low of $238000.0 during Q2 2025
- Its 4-year average for Current Leases is $610866.7, with a median of $685000.0 in 2022.
- Per our database at Business Quant, Phathom Pharmaceuticals' Current Leases surged by 4530.61% in 2023 and then plummeted by 6694.44% in 2025.
- Phathom Pharmaceuticals' Current Leases (Quarter) stood at $708000.0 in 2022, then increased by 2.54% to $726000.0 in 2023, then tumbled by 30.99% to $501000.0 in 2024, then increased by 17.96% to $591000.0 in 2025.
- Its last three reported values are $591000.0 in Q3 2025, $238000.0 for Q2 2025, and $316000.0 during Q1 2025.